Hiroo Imazu

Nihon University — Japan

Medicine · Health Sciences

26h-index3.0kcitations132works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(36), Gallbladder and Bile Duct Disorders(25), Renal and related cancers(18), Liver Disease and Transplantation(16), Pancreatitis Pathology and Treatment(16)

Publications132 total

Usefulness of simplified comprehensive geriatric assessment as a pre‐<scp>ERCP</scp> screening for the elderly
Journal of Hepato-Biliary-Pancreatic Sciences·2024· 2 cited
Correlation between pathology and quantitative ultrasonographic evaluation of pancreatic fat with ultrasonographic classification
Journal of Medical Ultrasonics·2024
A comparison of diagnostic utility of new endoscopic scraper combined cell block method and conventional brush catheter for biliary tract cancer
DEN Open·2024· 1 citedOpen Access
Diagnostic utility of quantitative analysis of microRNA in bile samples obtained during endoscopic retrograde cholangiopancreatography for malignant biliary strictures
PLoS ONE·2023· 3 citedOpen Access
The Usefulness of the Alpha-Retroflex Position in Biliary Cannulation on Single-Balloon Enteroscopy-Assisted Endoscopic Retrograde Cholangiopancreatography in Patients with Roux-en-Y Gastrectomy: A Retrospective Study
Gastroenterology Research and Practice·2023· 1 citedOpen Access
A case of hepatocellular carcinoma with ruptured gastric varices one month after the administration of a molecular-targeted drug
Progress of Digestive Endoscopy·2023Open Access
Su1094 DIAGNOSTIC UTILITY OF QUANTITATIVE ANALYSIS OF MICRORNA IN BILE SAMPLES OBTAINED DURING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY FOR MALIGNANT BILIARY STRICTURES
Gastroenterology·2023
Supplementary Figure Legend from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S2 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S3 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure Legend from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S2 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Data from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S3 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S3 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Data from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S2 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Hisao Tajiri(18), Hiroshi Fukui(12), Salem Omar(11), Tiing Leong Ang(11), Hitoshi Yoshiji(10), Kazuki Sumiyama(10), Ryuichi Noguchi(9), Shigeki Kuriyama(8), Junichi Yoshii(7), Yasuhide Ikenaka(7), Hirohisa Tsujinoue(7), Koji Yanase(7), Hiroshi Arakawa(7), Hiroshi Kakutani(7), Sadamu Homma(6), Kazuki Takakura(6), Keiichi Ikeda(6), Stefan Seewald(5), Stefan Groth(5), Uwe Seitz(5)